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Abstract
Background: This meta-analysis aimed to determine the bone union rate of bone defects treated with the different
autologous bone graft techniques.
Methods: The PubMed and the Cochrane Library databases were searched using the terms: ‘fracture’ AND (‘bone loss’
OR ‘defect’ OR ‘defects’) AND ‘bone graft’, restricted to English language, to human species, and to a publication period
from January 1999 to November 2014. Data were extracted by one of the reviewers and then checked by the second.
A quality of evidence score and a methodology score were used. Heterogeneity was assessed. A random effects model
approach was used to combine estimates.
Results: Out of 376 selected studies only 34 met the inclusion criteria. The summary pooled union rate was 91 % (95 %
CI: 87–95 %) while union rate after additional procedures raised to 98 % (95 % CI 96–99 %). No association between
union rate and bone defect size was found. (Univariable regression model: vascularized: P = 0.677; non-vascularized: 0.202.
Multivariable regression model: vascularized: P = 0.381; non-vascularized: P = 0.226). Vascularized graft was associated with
a lower risk of infection after surgery when compared to non-vascularized graft (95 % CI 0.03 to 0.23, p < 0.001).
Conclusion: The results of this meta-analysis demonstrate the effectiveness of autologous graft for bone defects.
Furthermore, from the available clinical evidence bone defect size does not seem to have an impact on bone union
when treated with autologous bone graft techniques.
Keywords: Bone graft, Segmental bone defect, Large bone defects, Bone reconstruction
Background
Conventional autologous bone graft has become the
most widely used treatment for bone defects over time.
Several factors contributed to its widespread application:
it is easy to obtain, it combines osteogenic, osteoinductive
and osteoconductive properties, it does not raise immune
response or transmit infectious diseases [1, 2]. Further-
more, autologous bone graft can be harvested in a variety
of forms and sizes from different donor sites [1, 2].
Selection of the autologous graft type in the treatment
of bone defects has been mostly based on defect size:
several authors do not recommend the use of the
non-vascularized graft in defects larger than 5 cm [1–3].
The more technical demanding vascularized bone graft
method is considered the best choice for larger size de-
fects [2, 3]. However, in recent years, advances in graft
harvesting technique [4] and in wound environment
recovery using the polymethylmethacrylate (PMMA) in-
duced membrane technique [5], renewed the interest in
the use of the non-vascularized autologous bone graft.
Infection also plays a role in graft selection and a 2-stage
approach with delayed grafting is sometimes necessary [6].
The primary objective of this meta-analysis is to deter-
mine the bone union rate of post-traumatic bone defects
treated with the different autologous bone graft tech-
niques. The secondary objective is to determine the rate
of infection after this treatment.
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Methods
Data collection and extraction
Prior to doing the electronic search, a written protocol
was established according to guidelines for systematic
reviews (AMSTAR, MOOSE and PRISMA) [7–9]. An
electronic search was conducted in Medline restricted to
English language, to human species, and to a publication
period from January 1999 to November 2014. The
search terms and Boolean operators used were: ‘fracture’
AND (‘bone loss’ OR ‘defect’ OR ‘defects’) AND ‘bone
graft’. Additionally an electronic search was done in the
Cochrane Library with the terms: fracture AND bone
loss AND defect OR defects AND bone graft.
Two reviewers (MA, AA) independently scrutinized
the list of titles of all the retrieved citations and, if neces-
sary, the abstracts to determine usefulness of the article.
The final selection was based on the full text version of
the potentially relevant articles that were assessed inde-
pendently by the reviewers. All references cited in these
elected studies were manually searched along with the
“related articles” researches in PubMed engine for addi-
tional relevant studies. Papers published by the same
research group and studying the same factors were
checked for duplicate data. Where duplication occured
the less detailed paper was discarded.
We included only original reports that presented the
results of at least ten cases of bone defects secondary to
open fractures, post-traumatic nonunion or infected
bone resection. The exclusion criteria were: bone defects
after tumor resection; bone defects after reduction and
fixation of closed metaphyseal fracture of long bones;
studies with more than 25 % of the defect not located in
long bones (forearm, humerus, femur or tibia); studies
with more than 25 % of the defects treated with osteo-
conductive biomaterials in addition to the bone graft;
cases with the use of osteoinductive factors in the graft;
studies mostly about bone defects in children and studies
that did not report the information about healing after
treatment. When the information of each patient in a
study was presented in the text and/or tables, cases
that met the exclusion criteria were removed and the
remaining patients were enrolled in the analysis.
Included studies were classified according the Oxford
Centre for Evidence-Based Medicine system and a modi-
fied version of the Coleman methodology score [10]
(Additional file 1). Data was extracted by one of the re-
viewers and then checked by the second. Disagreements
were solved via discussion and consensus between the
two reviewers. The following definitions were used for
data extraction: primary union described as bone union
achieved after bone grafting, secondary union as bone
union achieved with a further surgery after the bone
graft. Of note, a graft fracture was considered a union re-
lated complication only when the original study classified
it in this manner, and cases with union before lost of
follow up were considered as treated. Treatment failures
were viewed as the loss of the graft in the postoperative
period that required debridement and a new graft, the
absence of bone union during follow-up or a new bone
defect treatment (bone transport, amputation, etc.).
Preoperative infection refers to the presence of infec-
tion (active or quiescent) or absence of it when bone
defect treatment was implemented. Postoperative infec-
tion was infection reported as a complication after bone
graft procedure. We considered that PMMA was used
as an adjuvant in bone defect treatment (induced mem-
brane technique) only when authors reported its use
for this purpose.
Assessment of publication bias
Susceptibility of the systematic review to publication bias
was formally assessed with the Egger test [11].
Quantitative data synthesis
To stabilize variance, the bone union proportions were
subject to a Freeman-Tukey arcsine square root trans-
formation and back-transformed according to Miller
after quantitative data synthesis [12, 13]. With the nor-
malized data, heterogeneity was assessed using both
Cochran’s Q test and the inconsistency measure I2 sug-
gested by Higgins [14]. A cut-off of P < 0.10 was used to
indicate heterogeneity. Values of I2 equal to 25 %, 50 %
and 75 % denoted a low, moderate and high degree of
statistical heterogeneity. As data from a series of studies
that had been performed independently are thought to
be not functionally equivalent, a random effects model
approach was used to combine estimates. Confidence in-
tervals within studies were achieved using the exact bi-
nomial method. To perform a sub-group analysis, the
studies were divided according to graft vascularization in
two major categories: non-vascularized bone graft or
vascularized bone graft. Analyses were performed using




The Medline search resulted in 338 citations and after
the abstract review 21 were considered as potentially
eligible and all of them had the full version reviewed.
References of these articles were manually screened and
also the related citations tool resulting in further 38 po-
tentially eligible articles, totaling 59 papers to review.
The Cochrane Library search did not result in additional
studies. After the full version review, 34 studies met the
inclusion/exclusion criteria (Fig. 1) (Additional file 2).
In seven of the 34 studies some cases were excluded
from the analysis (Additional file 3). A total of 749
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patients with 750 bone defects were included in this
meta-analysis.
Concerning study characteristics, one was a randomized
controlled trial, one was a prospective case series, three
were retrospective comparative case series and 29 were
retrospective case series (Table 1). Only Pelissier et al. [15]
was a comparison between vascularized and non vas-
cularized bone graft. The studies achieved 37.1 points
(21 to 72) out of 100 in the quality assessment tool.
The inter rater agreement in regards to the quality as-
sessment between the reviewers was considerably high
(ICC = 0.78; 95 % CI 0.75 to 0.94).
Publication bias
The shape of the funnel plot revealed evidence of
asymmetry for both primary and secondary union
(Fig. 2). The Egger’s test showed evidence of publica-
tion bias (p < 0.001 for primary union and p < 0.001 for
secondary union).
Bone union rate
Primary bone union was documented in 33 studies [15–47]
(Q = 87.53, df = 32, P <0.001; I2 = 63.4 %) and second-
ary bone union was documented in 34 studies [15–48]
(Q = 38.65, df = 33, P =0.23; I2 = 14.6 %). Union rates
as primary ranged between 48 % and 100 % across eli-
gible studies. Using random-effects weights, the summary
(pooled) union rate was 91 % (95 % CI: 87–95 %). Union
rates as secondary ranged between 81 % and 100 % across
eligible studies. Using random-effects weights, the sum-
mary (pooled) union rate was 98 % (95 % CI 96–99 %).
For comparison of vascularized versus non-vascularized
graft the study from Toh et al. [18] and the study from
Muramatsu et al. [20] were omitted as they used a mixed
technique. The study of Pelissier et al. [15] included pa-
tients treated either with vascularized or non-vascularized
graft, thus this publication contributed to both groups in
the sub-group analysis (Table 2).
When analyzing the primary bone union, significant
intra-group heterogeneity was observed (Vascularized:
Q = 37.07, df = 18, P < 0.01; I2 = 51.4 %; Non-vascularized:
Q = 47.48, df = 12, P < 0.001; I2 = 74.7 %). However, there
was no statistical difference between the two groups
(P = 0.372) supporting the pooling of all studies into
one pooled measure. Using random-effects weights,
the summary (pooled) union rate was 93 % (95 % CI:
89–97 %) for the vascularized group and 89 % (95 %
CI: 79–97 %) for the non-vascularized group (Fig. 3a).
Fig. 1 Flowchart of literature review
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Meta-regression was performed to investigate poten-
tial sources of heterogeneity within study for primary
bone union. The main factor investigated was bone de-
fect size additionally adjusted for age and proportion of
female patients. Both univariable and multivariable
meta-regression did not show any association of union
rate and bone defect size (Univariable: vascularized:
P = 0.677; non-vascularized: 0.202. Multivariable: vas-
cularized: P = 0.381; non-vascularized: P = 0.226).
When analyzing the secondary bone union, no signifi-
cant intra-group heterogeneity was observed (Vascularized:
Q = 18.22, df = 19, P = 0.508; I2 = 0.0 %; Non-vascularized:
Q = 15.20, df = 12, P = 0.231; I2 = 21.0 %), neither difference
between groups was noted (P = 0.106). Using random-
effects weights, the summary (pooled) secondary union
rate was 98 % (95 % CI: 97–100 %) for the vascularized
group and 96 % (95 % CI: 91–99 %) for the non-
vascularized group (Fig. 3b).
Table 1 Studies and cases descriptive characteristics
Authors Year Treatment period Study type LE (n) Age (y) [range] Male/female Bone defect location (femur/tibia/
humerus/foream/other bones)
FU (mts)
Ring et al. [16] 2000 nr R-CS IV 15 48 [22 - 80] 9/6 -/-/15/-/- 31
Tu et al. [17] 2001 1990–1993 R-CS IV 48 48 [15 - 62] 40/8 10/32/2/4/- 72
Toh et al. [18] 2001 1983–1998 R-CS IV 19 53 [21 - 84] 17/2 -/19/-/-/- 98
Heitmann et al. [19] 2002 nr R-CS IV 12 43 [16 - 79] 7/5 -/-/12/-/- tn
Muramatsu et al. [20] 2003 1985–2000 R-CS IV 13 51 [27 - 80] 6/7 -/-/13/-/- tn
Pelissier et al. [15] 2003 1984–1999 R(C)-CS IV 40 tn tn tn tn
Yajima et al. [21] 2004 1976–2000 R-CS IV 20 37 [17 - 73] 16/4 9/8/-/2/1 64
Lee et al. [22] 2004 1982–2001 R-CS IV 51 41 [15 - 66] 48/3 -/51/-/-/- nr
Adani et al. [23] 2004 1993–2000 R-CS IV 11 38 [16 - 65] 5/6 -/-/-/11/- tn
Ring et al. [24] 2004 1983–2001 R-CS IV 35 40 [21 - 66] 18/17 -/-/-/35/- 43
Yazar et al. [25] 2004 1993–2000 R-CS IV 61 37.5 [10 - 82] 42/19 7/49/-/-/6 58
Safoury [26] 2005 nr R-CS IV 18 34 [22 - 46] 16/2 -/-/-/18/- 36
Jones et al. [27] 2006 2000–2003 RCT II 15 38 [18 - 71] 13/2 -/15/-/-/- tn
El-Sayed et al. [28] 2007 nr R-CS IV 12 25 [12 - 40] 11/1 -/8/2/2/- 24
Ristiniemi et al. [29] 2007 2000–2004 R-CS IV 23 35 [14 - 75] 16/7 -/23/-/-/- nr
Adani et al. [30] 2008 1994–2004 R-CS IV 13 37 [21 - 62] 10/3 -/-/13/-/- nr
El-Gammal et al. [48] 2008 1995–2004 R(C)-CS IV 13 31.5 [nr] 11/2 -/13/-/-/- 38
Ryzewicz et al. [31] 2009 1998–2007 R(C)-CS IV 18 34.2 [18 - 51] 11/7 -/18/-/-/- nr
Allende et al. [32] 2009 1996–2008 R-CS IV 10 32.8 [11 - 56] 9/1 -/-/4/6/- tn
Cavadas et al. [33] 2010 2000–2008 R-CS IV 41 nr [17 - 64] 39/2 -/41/-/-/- nr
McCall et al. [34] 2010 2003–2007 P-CS IV 21 30.6 [nr] 13/8 5/15/-/1/- nr
Sun et al. [35] 2010 2005–2007 R-CS IV 10 31 [16 - 50] 9/1 3/7/-/-/- 26
Apard et al. [36] 2010 nr R-CS IV 12 40.6 [18 - 74] 10/2 -/12/-/-/- 39
Zhen et al. [37] 2010 2000–2007 R-CS IV 28 31.5 [17 - 56] 21/7 -/28/-/-/- 36
Chai et al. [38] 2010 2005–2007 R-CS IV 16 31 [16 - 50] 10/6 -/9/-/4/3 18
Georgescu et al. [39] 2011 1997–2007 R-CS IV 44 30.5 [5 - 66] 33/11 3/22/5/3/11 23
Chung et al. [40] 2011 1989–2007 R-CS IV 10 25.3 [16 - 43] 8/2 -/10/-/-/- 41
Niu et al. [41] 2011 2003–2008 R-CS IV 19 38.9 [18 - 61] 12/7 8/11/-/-/- nr
Liang et al. [42] 2012 1996–2006 R-CS IV 16 33.3 [21 - 46] nr 16/-/-/-/- 83
Gulan et al. [43] 2012 1991–1998 R-CS IV 10 30 [22 - 51] 10/0 -/10/-/-/- 144
Liang et al. [44] 2012 2001–2007 R-CS IV 14 34.3 [23 - 48] 11/3 14/-/-/-/- 67
Gao et al. [45] 2012 2004–2006 R-CS IV 18 34 [16 - 56] 13/5 7/11/-/-/- 40
Niu et al. [46] 2012 1993–2008 R-CS IV 22 33.8 [17 – 60] 14/8 -/-/22/-/- 39
Özaksar et al. [47] 2012 1993–2009 R-CS IV 21 32 [16 - 47] 19/2 -/21/-/-/- 74
LE level of evidence, n number of patients included in this review, y years, mts months, FU follow-up, R retrospective, P prospective, CS case series, C controlled,
RCT randomized controlled trial, nr not reported, tn technical note (see Additional file 3)
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Infection pre and post-treatment
Infection status of the cases was reported pre- and post-
operative in 22 studies [16, 18, 19, 21, 23, 24, 26, 27, 29–
33, 35, 36, 40, 41, 43–47]. The pooled estimate of mean
effect size showed about 6-fold decrease of infection
after treatment compared with pre-operative situation
(OR = 0.17 (95 % CI 0.08 to 0.36), p < 0.001; Q = 58.6,
p < 0.001, df = 21, I2 = 64.2 %). Therefore, a subgroup
analysis was performed. A significant decrease of post-
treatment infection was observed among the vascularized
graft group (n = 12; OR = 0.08 (95 % CI 0.03 to 0.23),
p < 0.001) but not in the non-vascularized group (n = 10;
OR = 0.43 (95 % CI 0.15 to 1.22), p = 0.114). Moreover, a
statistical difference between the two groups was found
(Q = 4.350; P = 0.037) (Fig. 4).
As heterogeneity in the subgroup analysis may be due
to the presence of outlying studies, a sensitivity analysis
was conducted excluding the studies that presented the
highest OR (Jones et al. [27], Ristiniemi et al. [29] and
Niu et al. [41]). After these studies were excluded a mode-
rate degree of heterogeneity (I2 = 63.7 %) was found. In
the sensitivity analysis there was no statistical difference
between the two techniques (Q = 1.146; P = 0.284) and the
non-vascularized group also showed a statistically signifi-
cant decrease of post-operative infection (n = 7; OR = 0.207
(95 % CI 0.06–0.77)).
Additionally, investigation of heterogeneity was per-
formed by means of meta-regression including age,
percentage of females and months of delay from in-
jury to treatment. No variables showed a significant
association with the risk of post-treatment infection.
Discussion
Bone union
The primary bone union rate expected for the bone graft
techniques is 91 %. In some circumstances, additional pro-
cedures such as the change of a broken implant, compres-
sion in the nonunion site or cancellous graft in nonunion
areas at bone ends, may be necessary and they raised the
union rate to 98 % in published studies (Additional file 4)
[15, 17–23, 25–31, 33–35, 39, 41, 42, 46–48].
Defect size as a guide to select graft
Only few studies presented a description of the method
used to define and measure the bone defect [27, 29, 31, 46].
Small defects that might have been susceptible to spon-
taneous regeneration were present in some studies.
They were treated not only with non-vascularized graft
but also with vascularized bone graft.
Studies about vascularized bone grafts have been per-
formed on larger bone defects but association of union
rate and bone defect size wasn’t found between the vas-
cularized and non-vascularized grafts. Limitations of this
conclusion include also a potential selection bias: some
recent studies about non-vascularized graft were ex-
cluded because of the addition of growth factor or bio-
material to the graft. Despite the limitation of this study,
our data suggests that selection of graft technique shall
not be guided only by defect size. Patient expectations,
surgeon experience, soft tissue condition and a trained
staff to perform microsurgery are elements that must be
carefully judged before making a decision on the graft to
be used.
Fig. 2 Funnel plot comparing proportion versus the standard error of proportion for the outcome of (a) primary union and (b) secondary
union. The assessment of the Egger test was coupled with an informal visual inspection of the funnel plot where circles represent studies
included in the meta-analysis. The solid vertical line indicates no union in terms of proportion. The outer dashed line indicate the triangular
region within which 95 % of studies are expected to lie in absence of both bias and heterogeneity (random effect pooled proportion
± 1.96 × standard error of pooled proportion). Asymmetry about the pooled proportion line is consistent with the presence of
publication bias
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Infection pre- post-treatment
The pooled estimate of mean effect size showed a de-
crease of infection after treatment compared with the
pre-operative situation. However, these findings should
be interpreted with caution due to the presence of a
moderate degree of statistical heterogeneity. According
Table 2 Graft type and healing rate per treatment
Authors n BD Mean (cm) Treatment type Donor area/associated technique
(n cases per treatment)
Primary union Secondary union
Nonvascularized bone graft
Ring et al. [16] 15 3 [2–6] ICBG ICBG (15) 93 % 93 %
Pelissier et al. [15] 16 4.3 [nr] ICBG ICBG (16) 75 % 81 %
Jones et al. [27] 15 4 [2.5–7] ICBG ICBG (15) 67 % 93 %
Ryzewicz et al. [31] 18 3.8 [2–6] ICBG ICBG (18) 89 % 94 %
Niu et al. [46] 22 tn [tn] ICBG ICBG (22) 95 % 100 %
Gulan et al. [43] 10 4 [2–7] ICBG ICBG (10) 100 % 100 %
Ring et al. [24] 35 2.2 [1–6] Multiple DS ICBG (33)/Ulna (4) 100 % 100 %
El-Sayed et al. [28] 12 7 [6–10] Multiple DS ICBG (8)/Fibula (12) 92 % 92 %
Niu et al. [41] 19 nr [nr] Multiple DS ICBG (19)/Fibula (2) 95 % 95 %
Ristiniemi et al. [29] 23 5.2 [3.5–10] ICBG + biomembrane ICBG (23)/biomembrane (23) 61 % 96 %
Allende et al. [32] 10 3.2 [1–7] ICBG + biomembrane ICBG (10)/biomembrane (10) 100 % 100 %
Apard et al. [36] 12 8.7 [6–15] ICBG + biomembrane ICBG (12)/TCF (4)/biomembrane (12) 92 % 92 %
McCall et al. [34] 21 6.6 [2–14.5] RIA + biomembrane RIA (21)/biomembrane (18) 48 % 81 %
Vascularized bone graft
Heitmann et al. [19] 12 9.2 [8–12] Free one DS Fibula (12) 75 % 92 %
Lee et al. [22] 51 10.5 [4.5–17] Free one DS Fibula (51) 92 % 98 %
Adani et al. [23] 11 8.7 [6–13] Free one DS Fibula (11) 73 % 82 %
Safoury [26] 18 nr [nr] Free one DS Fibula (18) 94 % 100 %
Adani et al. [30] 13 10.5 [6–16] Free one DS Fibula (13) 69 % 92 %
El-Gammal et al. [48] 13 12.6 [nr] Free one DS Fibula (13) nr 100 %
Sun et al. [35] 10 9.5 [6–17] Free one DS Fibula (10) 90 % 100 %
Zhen et al. [37] 28 nr [9–17] Free one DS Fibula (28) 100 % 100 %
Chai et al. [38] 16 13.8 [5–20] Free one DS Fibula (16) 100 % 100 %
Liang et al. [44] 14 6.9 [5–9] Free one DS Fibula (14) 100 % 100 %
Liang et al. [42] 16 16.4 [14–20] Free one DS Fibula (16) 94 % 100 %
Gao et al. [45] 18 9.2 [7–14] Free one DS Fibula (18) 100 % 100 %
Özaksar et al. [47] 21 10 [6–18] Free one DS Fibula (21) 81 % 95 %
Toh et al. [18] 19 4.9 [1–11] Pedicle one DS Fibula (19) 95 % 100 %
Chung et al. [40] 10 5.4 [4–8] Pedicle one DS Fibula (10) 100 % 100 %
Yajima et al. [21] 20 9.6 [3–24] Free + pedicle one DS Free fibula (16)/pedicle fibula (4) 85 % 90 %
Georgescu et al. [39] 44 8.2 [4–14] Free one DS Free rib (44) 98 % 98 %
Pelissier et al. [15] 24 9.8 [nr] Free multiple DS Fibula (12)/iliac (10)/arm (2) 88 % 88 %
Yazar et al. [25] 62 11.7 [6–18] Free multiple DS Fibula (50)/iliac (6)/rib (6) 87 % 95 %
Cavadas et al. [33] 41 nr [4–17] Free multiple DS + biomembrane Fibula (38)/iliac (3)/
biomembrane (32)
98 % 100 %
Nonvascularized and vascularized
bone graft
Muramatsu et al. [20] 13 1.8 [1–4] Free multiple DS + ICBG Fibula (8)/femur (4)/scapula
(1)/ICBG (8)
85 % 100 %
Tu et al. [17] 48 10.2 [6.5–19] Free multiple DS + ICBG Fibular (41)/iliac (4)/Rib (3)/ICBG (48) 94 % 100 %
n number of bone defects, ICBG iliac crest bone graft, DS graft donor site, TCF tricalcium phosphate, tn technical note (see Additional file 3)
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Fig. 3 Forest plot of bone union (% of union rates) in patients with vascularized and non-vascularized bone graft (random effects model). a Primary union
b Secondary union
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to the results of this meta-analysis, vascularized graft
showed a significant decrease of post-treatment infection.
Again, this conclusion is limited. Infection definition
varies between the included studies and several different
surgical techniques were used. Although we cannot give
evidence to support this recommendation, most of the
studies suggest a two step reconstruction as the standard
approach to manage infected bone defects: an extensive
debridement, followed by antibiotic treatment before graft
surgery [16, 21, 26, 29, 31, 32, 36, 40, 43, 44]. Furthermore,
some of the studies use PMMA as a local antibiotic de-
livery and/or due to its ability to induce a biological
membrane at the defect site [21, 29, 32–34, 36].
Overall completeness and applicability of evidence
The included studies provide the most complete infor-
mation available concerning union rates after autologous
graft for bone defects; however, different factors may
have added to the heterogeneity of the pooled results,
such as different treatment techniques, different sample
sizes reflecting different levels of experience, incomplete
information about complications. Additionally, informa-
tion regarding surgical steps was limited in several studies.
Finally, data concerning potential confounding factors,
such as patients selection criteria, soft tissue treatment
and definition of complications were also incomplete.
Quality of the evidence
The overall quality of the included studies is poor. Most
of them are nonrandomized observational studies with
serious limitations. There was evidence of publication
bias for primary and secondary bone union, with higher
union rates in bigger studies. Overall sample size allows
obtaining several statistically significant results. However,
the level of evidence of these findings is low or very low
due to the heterogeneity of the pooled data and the risk of
bias caused by the studies’ design.
Conclusion
This study states the effectiveness of autologous graft for
bone defects. Overall union rate was 91 % while union
rate after additional procedures raised to 98 % in pub-
lished studies. Available clinical evidence does not show
a direct relation between bone defect size and bone union
rate when autologous bone graft techniques were applied.
Therefore, bone defect size should not be the only factor
used when choosing between vascularized or non vascu-
larized bone graft. Finally, pooled analysis stated that in
the presence of infection, vascularized graft has a lower
risk of post-surgery infection. Well-designed randomized,
controlled trials are needed to raise the low level of
evidence for those conclusions.
Fig. 4 Forest plot of the odds ratio of bone infection before and after bone graft treatment stratified by type of graft (vascularized and non-vascularized)
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Additional file 1: Table modified Coleman methodology score for bone
defect. (DOCX 74 kb)
Additional file 2: Table studies excluded after full text review. (DOCX 99 kb)
Additional file 3: Table removed cases from included studies and
technical notes. Technical notes represent values related to the entire
sample of the studies where it was not possible to individualize data of
the included cases. (DOCX 52 kb)
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